Company-affiliated authors - The study was authored by Ivim Health employees, which does not invalidate the research but is a conflict of interest you should be aware of
That's why it's so important to understand why someone is struggling before considering whether a GLP-1 medication is appropriate
To address the issue, he started hormone therapy, which also gave him the opportunity to learn more about his vital organs and blood health
Estos hallazgos sugieren que la semaglutida puede ser una opcin prometedora para reducir los riesgos renales y cardiovasculares en esta poblacin de pacientes
How Retatrutide Could Fit Into a Whole-Body Plan at PRIME Medicine If a medication like retatrutide becomes part of someones care plan in the future, it works best when paired with a broader approach to metabolic health
In July 2024, the company released initial data for CT-996, first revealing that treatment resulted in a 7.3% drop in body weight.